Recent Studies from School of Medicine Add New Data to Obstetrics and Gynecology (The Effects of Vitamin D Supplement on Prevention of Recurrence of...
Clinical Trials Week
Recent Studies from
Our news journalists obtained a quote from the research from the School of Medicine, "The present study is a randomized controlled clinical trial which aims to determine the effect of vitamin D supplement on reducing the probability of recurrent preeclampsia. 72 patients were placed in control group while 70 patients were randomized to the intervention group. The intervention group received a 50000 IU pearl vitamin D3 once every two weeks. The control group was administered placebo. Vitamin D or placebo was given until the 36th week of pregnancy. The patients in intervention group have significantly lower (value=0.036) probability of preeclampsia than patients in the control group. The risk of preeclampsia for the control group was 1.94 times higher than that for the intervention group (95% CI 1.02, 3.71). The intended intervention (i.e., prescription of vitamin D) has a protective effect against recurrent preeclampsia. Vitamin D supplementation therapy in pregnancy could help in reducing the incidence of gestational hypertension/preeclampsia."
According to the news editors, the research concluded: "This study has been registered in Iranian Registry of Clinical Trials (IRCT) site with ID number IRCT."
For more information on this research see: The Effects of Vitamin D Supplement on Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of Preeclampsia.
Our news journalists report that additional information may be obtained by contacting
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC